Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma

Published:2012-06 Issue:2 Volume:141 Page:692-700
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Xie Rui-Fang,Li Zhi-Cheng,Gao Bo,Shi Zhi-Na,Zhou Xin

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference10 articles.

1. PI3K/Akt is involved in bufalin induced apoptosis in gastric cancer cells;Li;Anti-Cancer Drugs,2009

2. Pilot study of Huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer;Meng;Cancer,2009

3. Efficacy and safety of gemcitabine-oxaliplatin combined with Huachansu in patients with advanced gallbladder carcinoma;Qin;World Journal of Gastroenterology,2008

4. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells;Takai;International Journal of Molecular Medicine,2008

5. Involvement of caspase-3 activity and surviving downregulation in cinobufocini-induced apoptosis in A 549 cells;Wang;Experimental Biology and Medicine,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization;Journal of Ethnopharmacology;2024-03

2. Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression;Journal of Cellular and Molecular Medicine;2023-12-03

3. Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides;Molecular Cancer Therapeutics;2023-11-28

4. Toad venom bufadienolides and bufotoxins: An updated review;Drug Development Research;2023-05-08

5. A research update on the antitumor effects of active components of Chinese medicine ChanSu;Frontiers in Oncology;2022-09-27